<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="important target for the development of antiviral drugs, such as" exact="oseltamivir" post="(TamifluÂ®) and zanamivir, both of which target the enzymatic"/>
 <result pre="h post infection (Nakamura et al., 2013). Interestingly, co-administration of" exact="oseltamivir" post="and the antibody after lethal challenge significantly improved the"/>
 <result pre="2015). These studies also demonstrated improved protection when co-administered with" exact="oseltamivir" post="(Tharakaraman et al., 2015). When administered post infection, VIS401-treated"/>
</results>
